Avasimibe (CI-1011)

Catalog No. A10102

Avasimibe (CI-1011)是口服可生物利用的酰基辅酶A:胆固醇O-酰基转移酶(ACAT)抑制剂,IC50分别为2.9 μM, 13.9 μM和26.5 μM。
  • Yuyan Zhu, .et al. Pharmacological inhibition of acyl-coenzyme A:cholesterol acyltransferase alleviates obesity and insulin resistance in diet-induced obese mice by regulating food intake, Metabolism, 2021, Oct;123:154861 PMID: 34371065
Catalog Num A10102
M. Wt 501.7
Formula C29H43NO4S
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 166518-60-1
Synonyms CI-1011, CI1011, PD 148515
SMILES CC(C)C1=C(C(=CC=C1)C(C)C)OS(=O)(=O)NC(=O)CC2=C(C=C(C=C2C(C)C)C(C)C)C(C)C
Avasimibe (CI-1011)是口服可生物利用的酰基辅酶A:胆固醇O-酰基转移酶(ACAT)抑制剂,IC50分别为2.9 μM, 13.9 μM和26.5 μM。
Targets
CYP2C9 ACAT CYP1A2 CYP2C19
2.9 μM3.3 μM13.9 μM26.5 μM
In vitro (25°C) DMSO 96 mg/mL (191.34 mM)
Water Insoluble
Ethanol 8 mg/mL (15.94 mM)
In vivo 2% DMSO+corn oil 4 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 19.93 mL 99.66 mL 199.32 mL
0.5 mM 3.99 mL 19.93 mL 39.86 mL
1 mM 1.99 mL 9.97 mL 19.93 mL
5 mM 0.4 mL 1.99 mL 3.99 mL

*The above data is based on the productmolecular weight 501.7 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.